ArticleFrontiers in pharmacology2020

Commentary: "Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease" by Dankers M et al. in

Harma Alma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.